ARCA biopharma submits IND application to US FDA for a potential COVID-19 treatment EP News Bureau Sep 22, 2020 Pending FDA feedback, ARCA anticipates initiating the Phase 2b portion of a sequential Phase 2b/3 clinical evaluation of AB201 in…
